News Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Real-time Estimate Cboe BZX Other stock markets 01:37:32 2024-04-23 pm EDT			5-day change	1st Jan Change
3.425 ^USD	-53.46%		-54.83%	-30.04%

01:42pm	Top Premarket Decliners	MT
Apr. 22	Abeona Therapeutics Shares Slump After Plans to Reapply for Pz-cel Drug Approval	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Premarket Decliners	07:42am	MT
Abeona Therapeutics Shares Slump After Plans to Reapply for Pz-cel Drug Approval	Apr. 22	MT
Abeona Therapeutics Shares Down 53% After FDA Complete Response Letter	Apr. 22	DJ
US FDA declines to approve Abeona's skin disorder treatment	Apr. 22	RE
Abeona Therapeutics Provides Regulatory Update on Pz-cel	Apr. 22	AQ
Abeona Therapeutics Inc. Provides Regulatory Update on Pz-Cel	Apr. 22	CI
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 01	AQ
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	Mar. 18	MT
Sector Update: Health Care Stocks Rise Monday Afternoon	Mar. 18	MT
Sector Update: Health Care	Mar. 18	MT
Abeona Therapeutics Shares Fall After 2023 Results, FDA Observations on Cleveland Facility	Mar. 18	MT
Abeona Therapeutics Shares Drop 13% After FDA Inspection of Cleveland Facility	Mar. 18	DJ
Transcript : Abeona Therapeutics Inc., 2023 Earnings Call, Mar 18, 2024	Mar. 18
Abeona Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections	Mar. 18	AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	Mar. 06	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 05	AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 01	AQ
Abeona Says FDA Confirms Target Action Date For Pz-cel Application After Inspection	Feb. 01	MT
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)	Feb. 01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Summary

Filters